>Takeda's CSR >Basic Policies on CSR
For Takeda, CSR is rooted in putting the patient at the center and operating a pharmaceutical business that creates outstanding products. In addition, we strive to maintain and improve sound business processes, and to engage in activities to promote a sustainable society as a good corporate citizen. By creating and preserving value through CSR, we build trust with society, reinforce our reputation, and further develop the pharmaceutical business. In conducting our activities, we refer to internationally recognized guidelines, such as the United Nations Global Compact (UNGC)’s ten principles, and long-term international targets, such as the Sustain- able Development Goals (SDGs).
We refer to the seven internationally recognized guidelines shown below in promoting CSR activities that respond to the demands of society.
The International Integrated Reporting Council (IIRC) was established in 2010 by private-sector companies, investors, accounting associations, government agencies, and others, as an organization for developing an international corporate reporting framework.
Global Reporting Initiative (GRI) is a non-profit organization whose mission is to formulate international standards associated with sustainability. As an accredited group of the United Nations Environment Programme (UNEP), it has formulated the international standards of the “Sustainability Reporting Guidelines.”
AA1000 are the guidelines issued by British firm AccountAbility aimed at elevating accounting auditing and reporting systems through a systematic stakeholder engagement process.
In working with stakeholders such as NGOs and NPOs to promote CSR activities, we believe that it is important to take a holistic approach including cases conducted by Takeda alone, with other companies, and in what we call “producer-type” activities. Basedon this approach, we take into consideration various opportunities to create and sustain value for society and enterprises by promoting CSR activities.